Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: A final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group

British Journal of Haematology

Volumn 169, Issue 6, 2015, Pages 879-886

  Hirokawa, Makoto ^a   Sawada, Kenichi ^a   Fujishima, Naohito ^a   Teramura, Masanao ^b   Bessho, Masami ^c   Dan, Kazuo ^d   Tsurumi, Hisashi ^e   Nakao, Shinji ^f   Urabe, Akio ^g   Fujisawa, Shin ^h   Yonemura, Yuji ⁱ   Kawano, Fumio ^j   Oshimi, Kazuo ^k   Sugimoto, Koichi ^k   Matsuda, Akira ^l   Karasawa, Masamitsu ^m   Arai, Ayako ⁿ   Komatsu, Norio ^k   Harigae, Hideo ^o   Omine, Mitsuhiro ^p   Ozawa, Keiya ^q   Kurokawa, Mineo ^r   more..

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^g Kanto Teishin Hospital   (Japan)

^h YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

ⁱ KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION   (Japan)

^k JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^m GUNMA UNIVERSITY HOSPITAL   (Japan)

ⁿ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^o TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^p SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^q JICHI MEDICAL UNIVERSITY   (Japan)

^r UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Idiopathic; Immunosuppressive therapy; Large granular lymphocyte leukaemia; Pure red cell aplasia; Thymoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RELAPSE; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; THYMOMA; TREATMENT OUTCOME; ADOLESCENT; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; MIDDLE AGED; PROGNOSIS; RECURRENT DISEASE; RED-CELL APLASIA, PURE; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RED-CELL APLASIA, PURE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930274878     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13376     Document Type: Article

References (28)

1. Anderson, J.R., Cain, K.C. & Gelber, R.D. (1983) Analysis of survival by tumor response. Journal of Clinical Oncology, 1, 710-719.
2. Clark, D.A., Dessypris, E.N. & Krantz, S.B. (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood, 63, 277-286.
3. Dessypris, E. & Lipton, J. (2004) Red cell aplasia. In: Wintrobe's Clinical Hematology (eds. by Greer, J.P., Foerster, J., Lukens, J.N., Rodgers, G.M., Paraskevas, F. & Glader, B.), 11th edn, pp. 1421-1427. Lippincott Williams & Wilkins, Philadelphia.
4. Fasan, A., Kern, W., Grossmann, V., Haferlach, C., Haferlach, T. & Schnittger, S. (2013) STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia, 27, 1598-1600.
5. Fujishima, N., Hirokawa, M., Fujishima, M., Wada, C., Toyoshima, I., Watanabe, S. & Sawada, K. (2006) Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia. Haematologica, 91, Ecr47.
6. Fujishima, N., Sawada, K., Hirokawa, M., Oshimi, K., Sugimoto, K., Matsuda, A., Teramura, M., Karasawa, M., Arai, A., Yonemura, Y., Nakao, S., Urabe, A., Omine, M. & Ozawa, K. (2008) Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica, 93, 1555-1559.
7. Garcia-Suarez, J., Pascual, T., Munoz, M.A., Herrero, B. & Pardo, A. (1998) Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. American Journal of Hematology, 58, 319-325.
8. Go, R.S., Li, C.Y., Tefferi, A. & Phyliky, R.L. (2001) Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood, 98, 483-485.
9. Handgretinger, R., Geiselhart, A., Moris, A., Grau, R., Teuffel, O., Bethge, W., Kanz, L. & Fisch, P. (1999) Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. New England Journal of Medicine, 340, 278-284.
10. Hirokawa, M., Sawada, K., Fujishima, N., Nakao, S., Urabe, A., Dan, K., Fujisawa, S., Yonemura, Y., Kawano, F., Omine, M. & Ozawa, K. (2008) Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica, 93, 27-33.
11. Inui, Y., Yamamoto, K., Okamura, A., Yakushijin, K., Hayashi, Y., Matsuoka, H. & Minami, H. (2012) Isolated isochromosome 17q in myelodysplastic syndromes with pure red cell aplasia and basophilia. Internal Medicine, 51, 1579-1584.
12. Ishida, F., Matsuda, K., Sekiguchi, N., Makishima, H., Taira, C., Momose, K., Nishina, S., Senoo, N., Sakai, H., Ito, T. & Kwong, Y.L. (2014) STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. Cancer Science, 105, 342-346.
13. Jerez, A., Clemente, M.J., Makishima, H., Rajala, H., Gomez-Segui, I., Olson, T., McGraw, K., Przychodzen, B., Kulasekararaj, A., Afable, M., Husseinzadeh, H.D., Hosono, N., LeBlanc, F., Lagstrom, S., Zhang, D., Ellonen, P., Tichelli, A., Nissen, C., Lichtin, A.E., Wodnar-Filipowicz, A., Mufti, G.J., List, A.F., Mustjoki, S., Loughran, Jr, T.P. & Maciejewski, J.P. (2013) STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. Blood, 122, 2453-2459.
14. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Associations, 53, 457-481.
15. Kojima, M., Machida, S., Sato, A., Miyamoto, M., Moriuchi, M., Ohbayashi, Y. & Ando, K. (2013) Deferasirox treatment improved hematopoiesis and led to complete remission in a patient with pure red cell aplasia. International Journal of Hematology, 98, 719-722.
16. Krantz, S.B., Moore, W.H. & Zaentz, S.D. (1973) Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. The Journal of Clinical Investigation, 52, 324-336.
17. Lacy, M.Q., Kurtin, P.J. & Tefferi, A. (1996) Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood, 87, 3000-3006.
18. Lee, S.E., Yahng, S.A., Cho, B.S., Eom, K.S., Kim, Y.J., Lee, S., Min, C.K., Kim, H.J., Cho, S.G., Kim, D.W., Min, W.S., Park, C.W. & Lee, J.W. (2013) Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia. Acta Haematologica, 129, 72-77.
19. Masuda, M., Arai, Y., Okamura, T. & Mizoguchi, H. (1997) Pure red cell aplasia with thymona: evidence of T-cell clonal disorder. American Journal of Hematology, 54, 324-328.
20. Masuda, M., Saitoh, H. & Mizoguchi, H. (1999) Clonality of acquired primary pure red cell aplasia. American Journal of Hematology, 62, 193-195.
21. Mi, X., Hammill, B.G., Curtis, L.H., Greiner, M.A. & Setoguchi, S. (2013) Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators. Journal of Clinical Epidemiology, 66, S138-S144.
22. Oliva, E.N., Ronco, F., Marino, A., Alati, C., Pratico, G. & Nobile, F. (2010) Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients. Transfusion, 50, 1568-1570.
23. Sawada, K., Hirokawa, M., Fujishima, N., Teramura, M., Bessho, M., Dan, K., Tsurumi, H., Nakao, S., Urabe, A., Omine, M. & Ozawa, K. (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica, 92, 1021-1028.
24. Sawada, K., Fujishima, N. & Hirokawa, M. (2008) Acquired pure red cell aplasia: updated review of treatment. British Journal of Haematology, 142, 505-514.
25. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Van't Veer-Korthof, E. & Gluckman, E. (1993) Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. New England Journal of Medicine, 329, 1152-1157.
26. Suzuki, T., Tomonaga, M., Miyazaki, Y., Nakao, S., Ohyashiki, K., Matsumura, I., Kohgo, Y., Niitsu, Y., Kojima, S. & Ozawa, K. (2008) Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes. International Journal of Hematology, 88, 30-35.
27. Takatoku, M., Uchiyama, T., Okamoto, S., Kanakura, Y., Sawada, K., Tomonaga, M., Nakao, S., Nakahata, T., Harada, M., Murate, T. & Ozawa, K. (2007) Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. European Journal of Haematology, 78, 487-494.
28. Wang, S.A., Yue, G., Hutchinson, L., Landry, M.L., Hasserjian, R.P., Hao, S., Galili, N., Raza, A. & Woda, B.A. (2007) Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. British Journal of Haematology, 138, 271-275.